Studies towards the identification of potent, selective and bioavailable thrombin inhibitors

被引:9
作者
Ambler, J [1 ]
Baker, E [1 ]
Bentley, D [1 ]
Brown, L [1 ]
Butler, K [1 ]
Butler, P [1 ]
Farr, D [1 ]
Dunnet, K [1 ]
Le Grand, D [1 ]
Hayler, J [1 ]
Janus, D [1 ]
Jones, D [1 ]
Menear, K [1 ]
Mercer, M [1 ]
Smith, G [1 ]
Talbot, M [1 ]
Tweed, M [1 ]
机构
[1] Novartis Horsham Res Ctr, Horsham RH12 4AB, W Sussex, England
关键词
D O I
10.1016/S0960-894X(99)00061-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The application of selection criteria, based on potency and physicochemical parameters, to a candidate library of thrombin inhibitors is described. The utility of the approach is exemplified by the discovery of a potent, selective and bioavailable thrombin inhibitor 62. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:737 / 742
页数:6
相关论文
共 14 条
[1]   The discovery of orally available thrombin inhibitors: Studies towards the optimisation of CGH1668 [J].
Ambler, J ;
Baker, E ;
Brown, L ;
Butler, P ;
Farr, D ;
Dunnet, K ;
Le Grand, D ;
Janus, D ;
Jones, D ;
Menear, K ;
Mercer, M ;
Smith, G ;
Talbot, M ;
Tweed, M .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (24) :3583-3588
[2]  
Ammar HO, 1997, PHARMAZIE, V52, P627
[3]  
BRIGITTE K, 1998, DRUGS FUTURE, V23, P423
[4]  
Fareed Jawed, 1992, P63
[5]   THROMBIN STRUCTURE AND FUNCTION - WHY THROMBIN IS THE PRIMARY TARGET FOR ANTITHROMBOTICS [J].
FENTON, JW ;
OFOSU, FA ;
MOON, DG ;
MARAGANORE, JM .
BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (01) :69-75
[6]   HEPARINS [J].
HIRSH, J .
FIBRINOLYSIS, 1995, 9 :66-68
[7]   CHALLENGES IN THE DEVELOPMENT OF ORALLY BIOAVAILABLE THROMBIN ACTIVE-SITE INHIBITORS [J].
KIMBALL, SD .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) :511-519
[8]  
LEWIS SD, 1995, THROMB HAEMOSTASIS, V74, P1107
[9]  
RICH DH, PERSPECT MED CHEM, P1593
[10]   Antithrombotics serine proteases [J].
Ripka, WC ;
Vlasuk, GP .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 32, 1997, 32 :71-89